← Back
Data updated: Mar 10, 2026
NEPHRON
CardiovascularRespiratory
NEPHRON is a generic drug manufacturer focused on Cardiovascular, Respiratory.
1981
Since
11
Drugs
-
Trials
74
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
IPRATROPIUM BROMIDE 2026-02-23
BUDESONIDE 2026-01-26
Labeling
KETOROLAC TROMETHAMINE 2026-01-22
Labeling
ALBUTEROL SULFATE 2025-12-01
VERAPAMIL HYDROCHLORIDE 2025-11-24
ALBUTEROL SULFATE 2025-11-21
Labeling
VERAPAMIL HYDROCHLORIDE 2025-11-13
VERAPAMIL HYDROCHLORIDE 2025-09-19
Labeling
BUDESONIDE 2025-09-16
Labeling
ALBUTEROL SULFATE 2025-03-12
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 75%
1 drugs
Respiratory 25%
0 drugs Phase 2: 1
Pipeline Strength Pro
Loading...
Active (7)
Discontinued (4)
Company Info
- First Approval
- 1981-03-30
- Latest
- 2024-11-21
- Applications
- 13